![]() |
產(chǎn)地 | 進口、國產(chǎn) |
品牌 | 上海莼試 |
保存條件 | Store at -20 °C |
貨號 | CS11360 |
應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 |
CAS編號 | |
抗體名 | Anti-Senataxin/SETX |
克隆性 | |
靶點 | 詳見說明書 |
適應(yīng)物種 | 詳見說明書 |
形態(tài) | 詳見說明書 |
宿主 | 詳見說明書 |
亞型 | IgG |
標識物 | 詳見說明書 |
濃度 | 1mg/1ml% |
免疫原 | KLH conjugated synthetic peptide derived from human SLC14A2/UT-A |
肌萎縮側(cè)索硬化癥相關(guān)蛋白4抗體說明書 英文名稱 Anti-Senataxin/SETX
中文名稱 肌萎縮側(cè)索硬化癥相關(guān)蛋白4抗體說明書
別 名 ALS4; Amyotrophic lateral sclerosis 4 protein; AOA2; bA479K20.2; DKFZp781B151; FLJ12840; FLJ43459; KIAA0625; Probable helicase senataxin; SCAR1; SEN1 homolog; Setx; SETX_HUMAN.
產(chǎn)品屬性:
濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Dog, Cow, Horse, Sheep
產(chǎn)品類型 一抗
研究領(lǐng)域 神經(jīng)生物學(xué) 信號轉(zhuǎn)導(dǎo) 表觀遺傳學(xué)
蛋白分子量 predicted molecular weight: 303kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human Senataxin (321-398aa)
亞 型 IgG
純化方法 affinity purified by Protein A
儲 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
肌萎縮側(cè)索硬化癥相關(guān)蛋白4抗體說明書 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
(石蠟切片需做抗原修復(fù))
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 SETX belongs to the DNA2/NAM7 helicase family. Localizing to the nucleolus or the nucleoplasm in a cell cycle-dependent manner and to the cytoplasm, SETX contains a C-terminal DNA/RNA helicase domain and is believed to function as a helicase involved in RNA processing and DNA repair. Mutations in the gene encoding SETX can lead to ataxia-ocular apraxia 2 (AOA2) or amyotrophic lateral sclerosis 4 (ALS4). AOA2, also known as spinocerebellar ataxia-1 (SCAR1), is an autosomal recessive disorder characterized by progressive neurodegeneration of the cerebellum associated with the loss of Purkinje cells. ALS4 is a familial childhood- or adolescent-onset neurodegenerative disorder affecting both upper and lower motor neurons that ultimately results in fatal paralysis.
Function : Probable helicase, which may be involved in RNA maturation (By similarity). Involved in DNA double-strand breaks damage response generated by oxidative stress.
Subcellular Location : nucleolus. Cytoplasm. May be detected in the nucleolus only in cycling cells (By similarity). Most abundant in the nucleus. Detected in granules. Colocalized in cycling cells with FBL in the nucleolus.
Tissue Specificity : Highly expressed in skeletal muscle. Expressed in heart, fibroblast, placenta and liver. Weakly expressed in brain and lung. Expressed in the cortex of the kidney (highly expressed in tubular epithelial cells but low expression in the glomerulus).
DISEASE : Defects in SETX are the cause of spinocerebellar ataxia autosomal recessive type 1 (SCAR1) [MIM:606002]; also known as ataxia-ocular apraxia 2. Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR1 is an autosomal recessive form associated with peripheral neuropathy and elevated serum alpha-fetoprotein, immunoglobulins and, less commonly, creatine kinase levels. Some SCAR1 patients manifest oculomotor apraxia.
Defects in SETX are a cause of amyotrophic lateral sclerosis type 4 (ALS4) [MIM:602433]. ALS4 is a familial form of amyotrophic lateral sclerosis, a neurodegenerative disorder affecting upper and lower motor neurons and resulting in fatal paralysis. Sensory abnormalities are absent. Death usually occurs within 2 to 5 years. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of cases leading to familial forms. ALS4 is a childhood- or adolescent-onset form characterized by slow disease progression and the sparing of bulbar and respiratory muscles.
Similarity : Belongs to the DNA2/NAM7 helicase family.
Database links : UniProtKB/Swiss-Prot: Q7Z333.4
實驗流程:
全、新、優(yōu)、品、好四大特點:
肌萎縮側(cè)索硬化癥相關(guān)蛋白4抗體說明書 全:公司提供上萬種產(chǎn)品,涵蓋了生物試劑,elisa試劑盒,標準品,培養(yǎng)基,原裝耗材,抗體、培養(yǎng)基、ATCC細胞等,基本上各種科研所需產(chǎn)品在我司都能找到。
新:產(chǎn)品更新速度較快,基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu):產(chǎn)品質(zhì)量好,投訴比較少。
好:我公司具有優(yōu)質(zhì)的技術(shù)團隊,產(chǎn)品一旦售出,實驗過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時沒有任何的后顧之憂。
正在熱銷的相關(guān)產(chǎn)品:
Anti-V.cholera Ogawa/FITC 熒光素標記01群小川型霍亂弧菌抗體IgGMulti-class antibodies規(guī)格: 0.2ml
CD40L(CD40 Ligand/TNFSF5/CD154) CD40L抗原Multi-class antibodies規(guī)格: 0.5mg
細胞周期相關(guān)激酶抗體 Anti-CCRK 0.1ml
Smad1 英文名稱: 細胞信號轉(zhuǎn)導(dǎo)分子Smad-1抗體 0.1ml
EDG8 英文名稱: 內(nèi)皮細胞分化G蛋白偶聯(lián)受體8抗體 0.1ml
Rhesus antibody Rh phospho-HDAC7 (Ser318) 磷酸化組蛋白去乙酰化酶7抗體 規(guī)格 0.1ml
CD40L(CD40 Ligand/TNFSF5/CD154) CD40L抗原Multi-class antibodies規(guī)格: 0.5mg
Anti-phospho-P53 (Thr18) /FITC 熒光素標記磷酸化抑制基因P53抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Rabbit Anti-chicken IgM/Biotin 生物素化兔抗雞IgMMulti-class antibodies規(guī)格: 0.3ml
促腎上腺皮質(zhì)激素釋放因子 Anti-CRF 0.1ml
Rabbit Anti-mouse IgM/AP 堿性磷酸酶(AP)標記的兔抗小鼠IgM 0.1ml
FHAD1 英文名稱: 叉頭相關(guān)結(jié)構(gòu)域包含蛋白1抗體 0.2ml
Rhesus antibody Rh Phospho-Zap-70 (Tyr315/Tyr319) 磷酸化zeta相關(guān)蛋白70抗體 規(guī)格 0.1ml
Rabbit Anti-chicken IgM/Biotin 生物素化兔抗雞IgMMulti-class antibodies規(guī)格: 0.3ml
ACE( ACE, testis-specific isoform precursor) 緊張素轉(zhuǎn)換酶(抗原)Multi-class antibodies規(guī)格: 0.5mg
Anti-APS APS抗體Multi-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh phospho-C CBL(Tyr674) 磷酸化原癌基因CBL2抗體 規(guī)格 0.1ml
胃蛋白酶工作液(水劑、強度消化) 10ml PH 2.2, 0.5% in 5mM HCl
Valine 英文名稱: 纈酸抗體 0.1ml
Alpha Dystroglycan 英文名稱: 肌相關(guān)蛋白DAG1抗體 0.1ml
Anti-APS APS抗體Multi-class antibodies規(guī)格: 0.2ml
IL36G Protein Human 重組人 IL36G / IL1F9 蛋白
小鼠完全培養(yǎng)基 100mL
EFNA5 Others Rat 大鼠 Ephrin-A5 / EFNA5 人細胞裂解液 (陽性對照)
3T6-Swiss albino小鼠胚胎成纖維細胞 3T6-Swiss albino mouse embryo fibroblasts DMEM培養(yǎng)基+10%FBS
CL-0378MC3T3-E1 Subclone 14(小鼠顱頂前骨細胞亞克隆14)5×106cells/瓶×2
NCI-H2452(人間皮瘤細胞) 5×106cells/瓶×2 SW620(細胞)
CM-R045大鼠小腸粘膜上皮細胞完全培養(yǎng)基100mL
HA Others H7N9 甲型 H7N9 (A/Anhui/1/2013) 血凝素 (Hemagglutinin / HA) 人細胞裂解液 (陽性對照)
人臍內(nèi)皮細胞HUVEC
NCI-H226[H226]細胞,人細胞 人膀胱移行細胞癌細胞,T24細胞 人絨毛膜內(nèi)皮細胞HVCEC
鼬肺上皮細胞;MV-1-Lu
MMP1 Others Human 人 MMP1 人細胞裂解液 (陽性對照)
肌萎縮側(cè)索硬化癥相關(guān)蛋白4抗體說明書 IL36G Protein Human 重組人 IL36G / IL1F9 蛋白
小鼠完全培養(yǎng)基 100mL
EFNA5 Others Rat 大鼠 Ephrin-A5 / EFNA5 人細胞裂解液 (陽性對照)
3T6-Swiss albino小鼠胚胎成纖維細胞 3T6-Swiss albino mouse embryo fibroblasts DMEM培養(yǎng)基+10%FBS
CL-0378MC3T3-E1 Subclone 14(小鼠顱頂前骨細胞亞克隆14)5×106cells/瓶×2
NCI-H2452(人間皮瘤細胞) 5×106cells/瓶×2 SW620(細胞)
技術(shù)外包服務(wù):
★肌萎縮側(cè)索硬化癥相關(guān)蛋白4抗體說明書 分子生物學(xué):質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué):基因合成、引物合成、基因測序、載體構(gòu)建等
★蛋白工程:原核、哺乳動物蛋白表達系統(tǒng)等
★病毒包裝:腺病毒、慢病毒等
★抗體工程:磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細胞工程:細胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細胞培養(yǎng)、細胞膜制備、穩(wěn)定細胞株構(gòu)建、細胞RNAi技術(shù)等等。